Insider / Cigna Group
Hathi Neesha
Director at Cigna Group
- Company
- Cigna Group
- First filing on record
- April 24, 2026
- Latest trade on record
- October 1, 2026
- SEC filings
- EDGAR ↗
Hathi Neesha, Director at Cigna Group, has disclosed 10 transactions in SCHW, CI since April 24, 2026: 0 purchases (0 open-market buys) and 3 sales, worth about $1.7M at the reported prices. The latest was filed October 5, 2026, 4 days after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Hathi Neesha made no purchases and 3 sales worth $1.2M, plus 7 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Hathi Neesha has traded 1 stock on record; the largest by dollars is SCHW.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 6 | 22,708 | $541K |
| S | Open-market sale | 3 | 11,354 | $1.2M |
| A | Grant or award | 1 | 782 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 10 | 0 | 3 · $1.2M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| SCHW | Option / conversion M | October 1, 2026 | October 5, 2026 | 4d | 5,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| SCHW | Sell S | October 1, 2026 | October 5, 2026 | 4d | 5,000 | $98 | $489K | 10b5-1 planindirect | Form 4 ↗ | |
| SCHW | Option / conversion M | October 1, 2026 | October 5, 2026 | 4d | 5,000 | $42 | $210K | 10b5-1 plan | Form 4 ↗ | |
| SCHW | Option / conversion M | September 1, 2026 | September 2, 2026 | 1d | 3,177 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| SCHW | Sell S | September 1, 2026 | September 2, 2026 | 1d | 3,177 | $109 | $346K | 10b5-1 planindirect | Form 4 ↗ | |
| SCHW | Option / conversion M | September 1, 2026 | September 2, 2026 | 1d | 3,177 | $52 | $165K | 10b5-1 plan | Form 4 ↗ | |
| SCHW | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 3,177 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| SCHW | Sell S | August 28, 2026 | August 31, 2026 | 3d | 3,177 | $108 | $343K | 10b5-1 planindirect | Form 4 ↗ | |
| SCHW | Option / conversion M | August 28, 2026 | August 31, 2026 | 3d | 3,177 | $52 | $165K | 10b5-1 plan | Form 4 ↗ | |
| CI | Other A | April 22, 2026 | April 24, 2026 | 2d | 782 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 5, 2026 | Form 4 | 0001879974-26-000015 | 3 | published | EDGAR ↗ |
| September 2, 2026 | Form 4 | 0001879974-26-000013 | 3 | published | EDGAR ↗ |
| August 31, 2026 | Form 4 | 0001879974-26-000010 | 3 | published | EDGAR ↗ |
| April 24, 2026 | Form 4 | 0001739940-26-000035 | 1 | published | EDGAR ↗ |
Other insiders at Cigna Group
- Schwab Charles R. Co-Chairman 45 rows
- Bettinger Walter W Co-Chairman 28 rows
- Cordani David Chairman & CEO 27 rows
- Murtagh Nigel J Chief Risk Officer 22 rows
- Woolway Paul V MD, Chief Banking Officer 21 rows
- Craig Jonathan M. MD, Head of Investor Services 20 rows
- Kurian George Director 20 rows
- Brown Marianne Catherine Director 19 rows
- Ellis Stephen A Director 18 rows
- Beatty Jonathan S MD, Head of Advisor Services 17 rows
Everyone on file, with contracts and lobbying under the company's name: Cigna Group.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 10 | April 24, 2026 | October 5, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.